Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

United States

UCSD, La Jolla, California

Mercy Medical Center, Merced, California

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

Central Coast Medical Oncology, Santa Maria, California

Mission Hope Health Center, Santa Maria, California